ATE81974T1 - Verwendung von 2-(2-phenyl-2-(2-pyridyl)>ethyl-2- imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums. - Google Patents
Verwendung von 2-(2-phenyl-2-(2-pyridyl)>ethyl-2- imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums.Info
- Publication number
- ATE81974T1 ATE81974T1 AT88106677T AT88106677T ATE81974T1 AT E81974 T1 ATE81974 T1 AT E81974T1 AT 88106677 T AT88106677 T AT 88106677T AT 88106677 T AT88106677 T AT 88106677T AT E81974 T1 ATE81974 T1 AT E81974T1
- Authority
- AT
- Austria
- Prior art keywords
- imidazoline
- pyridyl
- phenyl
- ethyl
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Sorption Type Refrigeration Machines (AREA)
- Percussion Or Vibration Massage (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10372787 | 1987-04-27 | ||
EP88106677A EP0288978B1 (de) | 1987-04-27 | 1988-04-26 | Verwendung von 2-[2-Phenyl-2-(2-pyridyl)]ethyl-2-imidazolin oder eines Salzes davon zur Herstellung eines Antiasthmatikums |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE81974T1 true ATE81974T1 (de) | 1992-11-15 |
Family
ID=14361688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88106677T ATE81974T1 (de) | 1987-04-27 | 1988-04-26 | Verwendung von 2-(2-phenyl-2-(2-pyridyl)>ethyl-2- imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums. |
Country Status (15)
Country | Link |
---|---|
US (1) | US4874772A (de) |
EP (1) | EP0288978B1 (de) |
KR (1) | KR880012228A (de) |
AT (1) | ATE81974T1 (de) |
AU (1) | AU611145B2 (de) |
CA (1) | CA1309027C (de) |
DE (1) | DE3875647T2 (de) |
DK (1) | DK226688A (de) |
ES (1) | ES2052634T3 (de) |
GR (1) | GR3006610T3 (de) |
HU (1) | HU203665B (de) |
IL (1) | IL86151A (de) |
NO (1) | NO881798L (de) |
PH (1) | PH24155A (de) |
ZA (1) | ZA882737B (de) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5936885B2 (ja) * | 1976-06-24 | 1984-09-06 | 第一製薬株式会社 | 糖尿病治療剤 |
JPS60123418A (ja) * | 1983-12-07 | 1985-07-02 | Dai Ichi Seiyaku Co Ltd | 血管拡張剤 |
-
1988
- 1988-04-19 CA CA000564532A patent/CA1309027C/en not_active Expired - Lifetime
- 1988-04-19 ZA ZA882737A patent/ZA882737B/xx unknown
- 1988-04-22 IL IL86151A patent/IL86151A/xx not_active IP Right Cessation
- 1988-04-25 KR KR1019880004682A patent/KR880012228A/ko not_active Application Discontinuation
- 1988-04-25 NO NO881798A patent/NO881798L/no unknown
- 1988-04-26 ES ES88106677T patent/ES2052634T3/es not_active Expired - Lifetime
- 1988-04-26 DE DE8888106677T patent/DE3875647T2/de not_active Expired - Fee Related
- 1988-04-26 AT AT88106677T patent/ATE81974T1/de active
- 1988-04-26 DK DK226688A patent/DK226688A/da not_active Application Discontinuation
- 1988-04-26 EP EP88106677A patent/EP0288978B1/de not_active Expired - Lifetime
- 1988-04-27 US US07/186,859 patent/US4874772A/en not_active Expired - Fee Related
- 1988-04-27 HU HU882128A patent/HU203665B/hu not_active IP Right Cessation
- 1988-04-27 AU AU15190/88A patent/AU611145B2/en not_active Ceased
- 1988-04-27 PH PH36851A patent/PH24155A/en unknown
-
1992
- 1992-12-21 GR GR920403021T patent/GR3006610T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE3875647D1 (de) | 1992-12-10 |
KR880012228A (ko) | 1988-11-26 |
NO881798D0 (no) | 1988-04-25 |
NO881798L (no) | 1988-10-28 |
AU1519088A (en) | 1988-10-27 |
EP0288978A2 (de) | 1988-11-02 |
HUT46537A (en) | 1988-11-28 |
PH24155A (en) | 1990-03-22 |
ES2052634T3 (es) | 1994-07-16 |
DE3875647T2 (de) | 1993-03-18 |
AU611145B2 (en) | 1991-06-06 |
DK226688D0 (da) | 1988-04-26 |
ZA882737B (en) | 1988-10-17 |
IL86151A (en) | 1993-04-04 |
US4874772A (en) | 1989-10-17 |
HU203665B (en) | 1991-09-30 |
EP0288978A3 (en) | 1990-02-21 |
GR3006610T3 (de) | 1993-06-30 |
IL86151A0 (en) | 1988-11-15 |
EP0288978B1 (de) | 1992-11-04 |
CA1309027C (en) | 1992-10-20 |
DK226688A (da) | 1988-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3855113D1 (de) | Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht | |
ATE83659T1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
ATA68386A (de) | Verwendung von 3'-azido-3'-desoxythymidin oder eines pharmazeutisch annehmbaren derivats hievon zur herstellung von medikamenten | |
DE3585607D1 (de) | Verwendung von paroxetine zur herstellung eines arzneimittel zur behandlung von obesitaet. | |
DE59000270D1 (de) | Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen. | |
FI890311A0 (fi) | Kemiska foereningar. | |
NO902800L (no) | Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener. | |
DE3785740D1 (de) | Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie. | |
DE68904462D1 (de) | 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten. | |
DE69420679D1 (de) | Verwendung der 1-4-4-Aryl(oder Heteroaryl)-1-Piperazinylbutyl-1H-Azol-Derivate zur Herstellung von Arzneimitteln zur Behandlung der Störungen der Magensekretion | |
PT86859A (pt) | Process for the preparation of 9-ethyl-6,9-di-hydro-4,6-dioxo-10-propyl-4h-pyrano]3,2-g"-quinoline-2,8-calcium dicarboxilate and of pharmaceutical compounds containing it | |
ATE81974T1 (de) | Verwendung von 2-(2-phenyl-2-(2-pyridyl)>ethyl-2- imidazolin oder eines salzes davon zur herstellung eines antiasthmatikums. | |
ES2016305B3 (es) | Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso. | |
DE3686097D1 (de) | Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht. | |
NO893256L (no) | Fremgangsmaate for fremstilling av furyltiazolderivater. | |
EP0370454A3 (en) | Renin-inhibiting amino diol derivatives | |
ATE121623T1 (de) | Verwendung von quinazolinen zur herstellung eines arzneimittels zur behandlung und vorbeugung von arrhythmie. | |
DE3777709D1 (de) | Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis. | |
DE69529070D1 (de) | Verwendung von 5,6-o-benzyliden-l-ascorbinsäure oder deren salze zur herstellung eines medikaments zur behandlung von hiv | |
DE3876448D1 (de) | Verwendung eines tripeptids zur herstellung einer pharmazeutischen zusammensetzung sowie eine pharmazeutische zusammensetzung und methode. | |
ATE53384T1 (de) | 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten. |